Seeing Is Believing
Currently out of the existing stock ratings of Rajan Sharma, 6 are a HOLD (37.5%), 5 are a BUY (31.25%), 5 are a SELL (31.25%).
Analyst Rajan Sharma, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 12.5% that have a potential upside of 80.11% achieved within 44 days. Previously, Rajan Sharma worked at DEUTSCHE BANK.
Rajan Sharma’s has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DBVT, DBV Technologies at 29-May-2025.
Analyst best performing recommendations are on MOR (MORPHOSYS AG ADR).
The best stock recommendation documented was for MOR (MORPHOSYS AG ADR) at 11/22/2023. The price target of $19.13 was fulfilled within 176 days with a profit of $14.58 (320.44%) receiving and performance score of 18.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$105
$-83.41 (-44.27%)
$95
6 months 29 days ago
(09-Dec-2025)
0/13 (0%)
$-72.77 (-40.93%)
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
7 months 13 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
8 months 11 days ago
(27-Oct-2025)
4/4 (100%)
$13.48 (10.43%)
88
Buy Since 30-May-2024
$97
1 years 3 months 8 days ago
(30-Mar-2025)
0/2 (0%)
$-43.8 (-31.11%)
Hold Since 12-Feb-2025
1 years 4 months 26 days ago
(12-Feb-2025)
6/6 (100%)
$29.07 (22.44%)
674
What Year was the first public recommendation made by Rajan Sharma?